⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 3, 2024Annals of MedicineOpen Access

Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center

Hsuan-Yu Chang Chia‐Chen Hsu Li-Fang Hu Chian‐Ying Chou Yuh‐Lih Chang Chih-Chia Lu Li-Jen Chang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Background Literature on the safety of remdesivir in hospitalized COVID-19 patients with severe renal impairment is limited. We aimed to investigate the safety and effectiveness of remdesivir in this population.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chang et al. (2024) studied this question.

synapsesocial.com/papers/68e66601b6db6435875f26ee https://doi.org/10.1080/07853890.2024.2361843

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment2024 · 2 citations
2Remdesivir and Renal Outcomes in Hospitalized COVID-19 Patients Without Severe Renal Impairment: A Retrospective Cohort Study2025
3Effectiveness of remdesivir in patients with COVID-19 and severe renal insufficiency: a nationwide cohort study in Japan2024 · 1 citations
4Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial2024 · 21 citations
5Complications of remdesivir in COVID-19 patients with kidney disease: a retrospective cohort studyCohort Study · 2025 · 1 citations